The test is designed to help clinicians either rule in or rule out amyloid pathology in patients showing signs of cognitive decline
New test expands access to early Alzheimer’s assessment, streamlining diagnostic pathways and improving referral efficiency
The Elecsys Amyloid Plasma Panel has the potential to ensure better identification of patients that require further confirmatory testing, supporting a more timely and accessible diagnosis.
Subscribe To Our Newsletter & Stay Updated
